The present invention relates to compounds according to Formula I:
or a pharmaceutically acceptable salt thereof wherein the variables are as defined in the claims. The compounds can be used as inhibitors of ROR³ and are useful for the treatment of ROR³ mediated diseases.
申请公布号
EP3101008(A1)
申请公布日期
2016.12.07
申请号
EP20150170764
申请日期
2015.06.05
申请人
Lead Pharma Cel Models IP B.V.;SANOFI
发明人
CADICAMO, Cosimo Damiano;CALS, Joseph Maria Gerardus Barbara;DE KIMPE, Vera;LEMMERS, Jaap Gerardus Henricus;NABUURS, Sander Bernardus
